Literature DB >> 30174866

Cancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis.

Han-Yu Deng1,2, Guha Alai1, Jun Luo1, Gang Li1, Ze-Guo Zhuo1, Yi-Dan Lin1.   

Abstract

BACKGROUND: Cancerous esophageal stenosis encountered during endoscopic ultrasonography before treatment was observed in about 30% of esophageal cancer patients. Since the pT stage in TNM classification measures only the depth of infiltration but not the growth to esophagus, it is interesting to know whether tumor growth into the esophagus (and eventual stenosis) is of added value in prognostic assessment. However, the impact of esophageal stenosis on survival of esophageal cancer patient remains unclear. Therefore, we conducted a meta-analysis focusing on current topic for the first time.
METHODS: A systematic literature search in PubMed and EMBASE was conducted to identify relevant studies up to 14 March 2018. Data of 5-year overall survival (OS) was extracted and analysed.
RESULTS: A total of five cohort studies consisting of 1,282 patients (278 patients with cancerous esophageal stenosis before treatment and 1,004 patients without) with esophageal cancer treated with surgery, chemoradiotherapy, or palliative therapy were included for analysis. Meta-analysis showed that patients with esophageal stenosis had significantly lower 5-year OS [22.3% and 33.0%, respectively; risk ratio (RR) =1.21; 95% CI, 1.11-1.32; P<0.001; I2=27.1%] than those without. No heterogeneity or publication bias was observed during analysis.
CONCLUSIONS: Patients with cancerous esophageal stenosis identified by endoscopy before treatment had significantly poorer survival than those without. High-quality studies with appropriate adjustments for confounding factor are needed to confirm the findings.

Entities:  

Keywords:  Esophageal cancer; esophageal stenosis; meta-analysis; prognosis

Year:  2018        PMID: 30174866      PMCID: PMC6106035          DOI: 10.21037/jtd.2018.06.89

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

Review 1.  Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review.

Authors:  Srinivas-R Puli; Jyotsna-Bk Reddy; Matthew-L Bechtold; Daphne Antillon; Jamal-A Ibdah; Mainor-R Antillon
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

2.  Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer.

Authors:  J-B Clavier; D Antoni; D Atlani; M Ben Abdelghani; C Schumacher; P Dufour; J-E Kurtz; G Noel
Journal:  Dis Esophagus       Date:  2012-10-26       Impact factor: 3.429

Review 3.  Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer.

Authors:  Charles J Lightdale; Ketan G Kulkarni
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

4.  Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction.

Authors:  M Hiele; P De Leyn; P Schurmans; A Lerut; S Huys; K Geboes; A M Gevers; P Rutgeerts
Journal:  Gastrointest Endosc       Date:  1997-05       Impact factor: 9.427

5.  Staging accuracy of endoscopic ultrasound based on pathologic analysis after minimally invasive esophagectomy.

Authors:  Brian R Smith; Kenneth J Chang; John G Lee; Ninh T Nguyen
Journal:  Am Surg       Date:  2010-11       Impact factor: 0.688

6.  Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma.

Authors:  C Mariette; J M Balon; V Maunoury; G Taillier; I Van Seuningen; J P Triboulet
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

Review 7.  Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.

Authors:  Han-Yu Deng; Wen-Ping Wang; Yun-Cang Wang; Wei-Peng Hu; Peng-Zhi Ni; Yi-Dan Lin; Long-Qi Chen
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

Review 8.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534

9.  Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).

Authors:  Tatsuya Okuno; Masashi Wakabayashi; Ken Kato; Masayuki Shinoda; Hiroshi Katayama; Hiroyasu Igaki; Yasuhiro Tsubosa; Takashi Kojima; Hiroshi Okabe; Yusuke Kimura; Tatsuyuki Kawano; Shinichi Kosugi; Yasushi Toh; Hoichi Kato; Kenichi Nakamura; Haruhiko Fukuda; Satoshi Ishikura; Nobutoshi Ando; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2017-07-17       Impact factor: 3.402

10.  Recurrence risk after Ivor Lewis oesophagectomy for cancer.

Authors:  Mael Chalret du Rieu; Thomas Filleron; Benoit Beluchon; Marine Humeau; Charles-Henri Julio; Eric Bloom; Laurent Ghouti; Sylvain Kirzin; Guillaume Portier; Bernard Pradère; Nicolas Carrère
Journal:  J Cardiothorac Surg       Date:  2013-11-21       Impact factor: 1.637

View more
  3 in total

1.  MicroRNA‑542‑3p represses OTUB1 expression to inhibit migration and invasion of esophageal cancer cells.

Authors:  Jun Sun; Yong Deng; Jin Shi; Wengang Yang
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

2.  Preoperative dilated esophagus is associated with a high risk of intrathoracic anastomotic leakage for patients with esophageal cancer.

Authors:  Ze-Guo Zhuo; Gang Li; Han-Yu Deng; Jun Luo; Gu-Ha Alai; Yun-Cang Wang; Yi-Dan Lin
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

3.  X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF-β signaling pathway in esophageal cancer cells.

Authors:  Yuxiang Jin; Xinye Lu; Mingdong Wang; Xuewei Zhao; Lei Xue
Journal:  Cell Biosci       Date:  2019-09-18       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.